This version of the registration was submitted prior to the Lobbying Transparency Act coming into force on May 4, 2020. Due to different information requirements at that time, the registration is presented in the following format.
Registration ID: 19716407
Submitted by lobbyist on: March 27, 2014 01:24:48 PM
Accepted by Registrar on: April 15, 2014 03:09:00 PM
Designated Filer Information
| Crawley, Tami Lynn |
| 4590 Windsor Street | |
|
Vancouver, BC, V5V 4P7
|
778-233-9785 |
| Canada |
Organization Information
| Bristol-Myers Squibb Canada |
| Pharmaceutical Manufacturer |
| 4590 Windsor Street | |
|
Vancouver, BC, V5V 4P7
|
778-233-9785 |
| Canada |
Relevant Affiliates
Government or Government Agency Funding
Other Controlling or Directing Interests
Active Registration Period
| March 27, 2014 | |
| September 23, 2014 |
Organization's In-House Lobbyists
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
discussions around funding of BMS drugs through Medical Benefits Pharmaceutical Funding Division
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | March 27, 2014 |
Health
Awarding, amendment or termination of a contract, grant or financial benefit
discussions around listing of BMS oncology drugs on the provincial Oncology Drug Formulary with BC Cancer Agency (Provincial Health Service Authority)
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Provincial Health Services Authority | April 15, 2014 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
discussions around funding of BMS drugs through Medical Benefits Pharmaceutical Funding Division
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | March 27, 2014 |
Health
Awarding, amendment or termination of a contract, grant or financial benefit
discussions around listing of BMS oncology drugs on the provincial Oncology Drug Formulary with BC Cancer Agency (Provincial Health Service Authority)
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Provincial Health Services Authority | April 15, 2014 |
|
|||||
|
|
BC Public Office Background
Lobbying Activities
Health
Awarding, amendment or termination of a contract, grant or financial benefit
discussions around funding of BMS drugs through Medical Benefits Pharmaceutical Funding Division
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Health | March 27, 2014 |
Health
Awarding, amendment or termination of a contract, grant or financial benefit
discussions around listing of BMS oncology drugs on the provincial Oncology Drug Formulary with BC Cancer Agency (Provincial Health Service Authority)
Target Contacts
| Target Type | Name | Title or Constituency | Date Added |
|---|---|---|---|
| Public Agency | Provincial Health Services Authority | April 15, 2014 |